Fernandes, Marta
Westover, M. Brandon
Zafar, Sahar F.
Funding for this research was provided by:
National Institutes of Health (R01NS102190, R01NS102574, R01NS107291, RF1AG064312, RF1NS120947, R01AG073410, R01HL161253, K23NS114201)
National Science Foundation (2014431)
Article History
Received: 1 May 2023
Accepted: 31 October 2023
First Online: 10 November 2023
Change Date: 12 November 2024
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1186/s12913-024-11896-y
Declarations
:
: We confirm that all methods were carried out in accordance with relevant guidelines and regulation. The need for informed consent was waived by the ethics committee/Institutional Review Board of Massachusetts General Brigham, because of the retrospective nature of the study. The research protocol was approved by the Mass General Brigham (MGB) Institutional Review Board.
: Not applicable.
: Dr. M. Brandon Westover has private equity as co-founder of Beacon Biosignals and receives compensation for consulting and scientific advisory roles. The other authors declare no competing interests.